NEWS

Vita Coco Stock Surges 22% on Strong Q1 Earnings Beat

Vita Coco Stock Surges 22% on Strong Q1 Earnings Beat and Raised 2026 Outlook

NEW YORK — Vita Coco Company Inc. shares skyrocketed more than 22% on Wednesday, April 29, 2026, trading around $63 in morning action after the coconut water and functional beverage maker delivered a strong first-quarter earnings beat and raised its full-year guidance, signaling robust consumer demand for healthier drink options.

Warren Buffett Resigns as Berkshire Hathaway CEO After Historic 60-Year Leadership

Warren Buffett, CEO of Berkshire Hathaway Inc, pauses while playing bridge as part of the company annual meeting weekend in Omaha, Nebraska U.S. May 6, 2018.
OMAHA, Neb. — Warren Buffett, the legendary investor who transformed Berkshire Hathaway from a struggling textile mill into a $1 trillion-plus conglomerate, announced his resignation as chief executive officer on Wednesday, ending one of the most remarkable runs in American business history after more than six decades at the helm.

GameStop Stock Slips 2% to $24.50 as Meme Momentum Cools in 2026

Young investors are sometimes seen skeptically following their role in the GameStop stock craze, but say they are clued in to the market's risks
NEW YORK — GameStop Corp. shares traded modestly lower at $24.50 in morning trading on Wednesday, April 29, 2026, down about 2.35% as the meme stock favorite consolidated following recent volatility and ahead of its next earnings report, reflecting a cooling of retail enthusiasm amid broader market caution.
GE HealthCare

GE HealthCare Stock Drops 11% After Q1 Miss and Cut 2026 Outlook on Tariffs, Costs

NEW YORK — GE HealthCare Technologies Inc. shares tumbled more than 11% on Wednesday, April 29, 2026, trading around $60.72 in morning action after the medical technology company reported first-quarter results that missed profit expectations and lowered its full-year 2026 guidance, citing tariff impacts, supply chain issues and higher operating costs.
More news
ASX 200 Top Gainers: Telix Pharma Jumps 3.23% on FDA

Top 5 ASX 200 Gainers Today: Codan Leads Sharp Rally on Profit Upgrade

SYDNEY — The S&P/ASX 200 showed mixed performance on Wednesday, April 29, 2026, but several individual stocks stood out with impressive gains, led by Codan Ltd which surged more than 15% after issuing a strong profit guidance upgrade that exceeded market expectations.
Codan Shares Surge 17% on Upgraded FY26 Guidance and Strong

Codan Shares Surge 17% on Upgraded FY26 Guidance and Strong Gold Detector Demand

SYDNEY — Codan Ltd shares rocketed more than 16% to $42.45 in morning trading on Wednesday, April 29, 2026, after the Australian technology company delivered robust first-half results earlier in the year and analysts highlighted upgraded expectations for full-year earnings driven by exceptional demand for its Minelab gold detectors.
ASX 200 Top Gainers: Telix Pharma Jumps 3.23% on FDA

S&P/ASX 200 Slips 0.11% to 8,701 as Mining Stocks Weigh on Market

SYDNEY — The S&P/ASX 200 index edged lower in early afternoon trading on Wednesday, April 29, 2026, closing the morning session at 8,701.1 after shedding 9.6 points or 0.11%, as weakness in mining and energy stocks offset gains in financials and consumer sectors amid mixed global cues and ongoing caution over Middle East tensions.
Greg Abel Faces First Berkshire Hathaway Annual Meeting as CEO

Greg Abel Faces First Berkshire Hathaway Annual Meeting as CEO on May 2, 2026

OMAHA, Neb. — Greg Abel will step onto the stage at the CHI Health Center on Saturday, May 2, 2026, for his first Berkshire Hathaway annual shareholder meeting as CEO, marking the end of Warren Buffett's six-decade dominance over the event and ushering in a new era for one of the world's most iconic conglomerates.
Diet Coke

Coca-Cola Stock Climbs 6% to $80 on Q1 Earnings Beat and Raised 2026 Outlook

NEW YORK — Coca-Cola Co. shares jumped more than 6% to $80.21 in morning trading on Tuesday, April 28, 2026, after the beverage giant reported first-quarter results that topped Wall Street expectations and raised its full-year earnings guidance, driven by resilient global demand for its higher-priced drinks and strong execution in emerging markets.
AxoGen Stock Rockets 12% on Q1 2026 Revenue Beat, Raised

AxoGen Stock Rockets 12% on Q1 2026 Revenue Beat, Raised Guidance and Debt-Free Balance Sheet

NEW YORK — AxoGen Inc. shares surged more than 11% on Tuesday, April 28, 2026, climbing to $43.98 in morning trading after the peripheral nerve repair company delivered a strong first-quarter revenue beat, posted adjusted profitability and raised its full-year 2026 guidance while announcing it had become debt-free following a successful public offering.
FTSE 100 Surges 0.8% Today as Oil Eases and Markets

Sanmina Stock Soars 21% on Massive Q2 Earnings Beat, $600M Buyback and AI Momentum

NEW YORK — Sanmina Corp. shares exploded more than 20% on Tuesday, April 28, 2026, surging to $226.90 in early trading after the electronics manufacturing services company delivered a blockbuster second-quarter earnings beat, raised its full-year outlook and announced a new $600 million share repurchase program fueled by explosive demand for AI infrastructure.
Omnicell Stock Explodes 23% on Q1 2026 Earnings Beat and

Omnicell Stock Explodes 23% on Q1 2026 Earnings Beat and Raised Full-Year Outlook

NEW YORK — Omnicell Inc. shares skyrocketed more than 23% on Tuesday, April 28, 2026, after the healthcare technology company reported a strong first-quarter earnings beat and raised its full-year profit guidance, signaling renewed confidence in its autonomous medication management solutions amid improving hospital spending.
Petrol Station

Australia Fuel Crisis Deepens as Diesel Prices Soar and Reserves Dwindle in 2026

SYDNEY — Australia's fuel crisis intensified this week as diesel prices remained near record highs and national reserves hovered at precarious levels, forcing the government to scramble for alternative supplies amid ongoing disruptions from the Middle East conflict that has choked global oil shipments through the Strait of Hormuz.
Netflix

Netflix Stock Dips to $91 as Buyback Boost Offsets Post-Earnings Jitters in 2026

NEW YORK — Netflix Inc. shares closed at $91.36 on Monday, April 28, down 1.17% or $1.08, as investors digested ongoing adjustments following the streaming giant's first-quarter earnings and a major $25 billion share repurchase authorization designed to support the stock amid moderating growth concerns.
Tesla watchers are expecting the company to unveil a prototype of its robotaxi -- and are watching with both anticipation and skepticism

Tesla Stock Climbs 0.63% to $378.67 as Robotaxi Optimism Builds

NEW YORK — Tesla Inc. shares rose 0.63% to close at $378.67 on Monday, extending a recent rebound as investors grew more optimistic about the company's autonomous driving technology and upcoming robotaxi unveiling, despite ongoing challenges in vehicle deliveries and global competition.
ASX 200 Top Gainers: Telix Pharma Jumps 3.23% on FDA

ASX 200 Falls 0.57% to 8,716.9 as Mining Stocks Drag Amid Global Economic Concerns

SYDNEY — The S&P/ASX 200 Index slipped 49.5 points, or 0.57%, to close at 8,716.9 on Monday, as weakness in the resources sector and cautious global sentiment weighed on the benchmark, erasing early gains and highlighting the market's vulnerability to commodity price fluctuations and overseas developments.
Oruka Therapeutics Shares Soar 19% on Positive Week 16 Psoriasis

Oruka Therapeutics Shares Soar 19% on Positive Week 16 Psoriasis Drug Trial Data

NEW YORK — Oruka Therapeutics Inc. (NASDAQ: ORKA) shares surged nearly 19% Monday to $82.41 in heavy trading after the clinical-stage biotech company reported strongly positive Week 16 interim data from its Phase 2a EVERLAST-A trial of ORKA-001, a novel half-life extended IL-23p19 monoclonal antibody for moderate-to-severe plaque psoriasis.
Veradermics Stock Explodes 43% After Positive Phase 3 Hair Loss

Veradermics Stock Explodes 43% After Positive Phase 3 Hair Loss Drug Trial Results

NEW YORK — Veradermics Inc. shares skyrocketed more than 42% Monday, surging to $96.60 in morning trading after the dermatology-focused biopharmaceutical company announced strongly positive topline results from its Phase 2/3 clinical trial of VDPHL01, an oral treatment for male pattern hair loss that demonstrated early, consistent and robust hair growth.
FTSE 100 Surges 0.8% Today as Oil Eases and Markets

Dow Jones Dips Slightly to 49,225 in Cautious Early Trading on April 27

NEW YORK — The Dow Jones Industrial Average opened modestly lower Monday, slipping 5.35 points or 0.011% to 49,225.36 in early trading as investors weighed mixed economic signals, persistent geopolitical tensions and anticipation of key inflation data later this week.
Oil Prices Plunge Below $95 as US-Iran Ceasefire Sparks Relief

Australia Fuel Crisis Eases Slightly as Reserves Hit 46 Days Amid Ongoing Global Tensions

SYDNEY — Australia's fuel supply situation showed modest signs of stabilization Monday as national petrol reserves reached 46 days — the highest level since the current crisis began — while diesel shortages at service stations continued to decline, though high prices and supply chain vulnerabilities persist due to disruptions in the Middle East.
ASX 200 Top Gainers: Telix Pharma Jumps 3.23% on FDA

ASX 200 Slips 0.21% to 8,768 as Mining Stocks Drag Amid Global Tensions

SYDNEY — The S&P/ASX 200 Index closed at 8,768.0 on Monday, shedding 18.5 points or 0.21% in a subdued session as weakness in mining and resources stocks offset modest gains elsewhere, reflecting ongoing investor caution amid geopolitical uncertainties and mixed global economic signals.

Pages

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next